Viewing StudyNCT00431951



Ignite Creation Date: 2024-05-05 @ 5:21 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00431951
Status: COMPLETED
Last Update Posted: 2017-07-27
First Post: 2007-02-02

Brief Title: Phase I Escalating Multiple-Dose ST-246 Safety Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers
Sponsor: SIGA Technologies
Organization: SIGA Technologies

Organization Data

Organization: SIGA Technologies
Class: INDUSTRY
Study ID: ST-246 RD PHS 1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: SIGA Technologies
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Institute of Allergy and Infectious Diseases NIAID NIH